All data are based on the daily closing price as of February 6, 2026
u

Universal Vision Biotechnology

3218.TWO
4.37 USD
-0.13
-2.89%

Overview

Last close
4.37 usd
Market cap
370.45M usd
52 week high
8.15 usd
52 week low
4.37 usd
Target price
5.35 usd

Valuation

P/E
11.9294
Forward P/E
N/A
Price/Sales
2.7879
Price/Book Value
3.1574
Enterprise Value
348.60M usd
EV/Revenue
2.6147
EV/EBITDA
5.9534

Key financials

Revenue TTM
133.32M usd
Gross Profit TTM
78.74M usd
EBITDA TTM
55.65M usd
Earnings per Share
0.37 usd
Dividend
0.24 usd
Total assets
194.87M usd
Net debt
N/A usd

About

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses for myopia, hyperopia, presbyopia, and astigmatism. Furthermore, it offers wholesale and retail of medical equipment, western medicine; purchase and sale of ophthalmic surgical investments, medical optical instruments; enterprise and medical project investment and consulting services; ophthalmology diagnosis; healthcare investment management; and provides vision correction treatments, nutritional supplements for eye protection. Universal Vision Biotechnology Co., Ltd. was founded in 1992 and is based in Taipei, Taiwan.
  • Symbol
    3218.TWO
  • Exchange
    TWO
  • Isin
    TW0003218004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Medical Care Facilities
  • CEO
    Ms. Shu-Hsin Lin
  • Headquarter
    Taipei
  • Web site
    https://www.uvb.com.tw/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top